---
title: "Novo Nordisk AS raises its acquisition offer for Metsera to $10 billion"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/264472059.md"
description: "Novo Nordisk's stock price fell 3.9% in early trading on Wednesday in the U.S. after it raised its acquisition offer for Metsera to $10 billion, exceeding Pfizer's $8.1 billion bid. Meanwhile, a judge rejected Pfizer's request to block Novo Nordisk's acquisition, and the antitrust and merger rights litigation is still ongoing"
datetime: "2025-11-05T16:06:11.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/264472059.md)
  - [en](https://longbridge.com/en/news/264472059.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/264472059.md)
---

> Supported Languages: [简体中文](https://longbridge.com/zh-CN/news/264472059.md) | [繁體中文](https://longbridge.com/zh-HK/news/264472059.md)


# Novo Nordisk AS raises its acquisition offer for Metsera to $10 billion

In early trading on Wednesday, shares of Novo Nordisk fell 3.9% after reports indicated that the company would raise its offer for Metsera to a maximum of $10 billion, surpassing Pfizer's bid of $8.1 billion; during the antitrust and merger litigation, the judge rejected Pfizer's request to block Novo Nordisk's acquisition attempt

### Related Stocks

- [Novo Nordisk A/S (NVO.US)](https://longbridge.com/en/quote/NVO.US.md)
- [Metsera, Inc. (MTSR.US)](https://longbridge.com/en/quote/MTSR.US.md)

## Related News & Research

- [BREAKINGVIEWS-Novo Nordisk is Denmark’s big little problem: podcast](https://longbridge.com/en/news/280570178.md)
- [Novo Nordisk slashes Wegovy prices to court uninsured patients](https://longbridge.com/en/news/281206892.md)
- [Novo Nordisk A/S Approves Board Changes](https://longbridge.com/en/news/280694583.md)
- [Novo Nordisk Voucher Win Meets Rising Scrutiny Of FDA Review Program](https://longbridge.com/en/news/280885256.md)
- [NHS clears Wegovy to reduce risk of heart attack and stroke](https://longbridge.com/en/news/281323250.md)